Feature | Radiology Business | December 17, 2019 | Dave Fornell, Editor

Fujifilm Contemplating Purchase of Hitachi Medical Systems

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fufifilm capture a parger portion of international radiology market share. Photo by Dave Fornell.

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fujifilm capture a larger portion of international radiology market share. Photo by Dave Fornell.

December 17, 2019 — It was disclosed today that Fujifilm may buy Hitachi's diagnostic imaging business in a deal that could be worth about $1.55 billion. This was according to the Nikkei Asian Review business daily, which first broke the story early on Dec. 17. 

The acquisition would be designed to expand Fujifilm's footprint in the radiology market to better complete internationally with the big three medical imaging companies — GE Healthcare, Siemens Healthineers and Philips Healthcare. Worldwide, the big three vendors control more than 60 percent of the medical imaging market.

Nikkei reported Fujifilm has been beefing up its medical equipment business, particularly endoscopy and X-ray imaging. It is turning its attention to the CT scanners, MRI devices and workhorse ultrasound severs, which Hitachi specializes in and Fujifilm is missing from its current radiology portfolio. 

Both company are also working on artificial intelligence (AI) applications for medical imaging. The merger would help expand Fujifilm's REiLE AI suite of AI products. Hitachi also offers software tools and AI to speed workflow and aid completion of medical imaging reports. 

The Board of Directors for both Fujifilm and Hitachi are supposed to hold meetings to vote on the proposed deal Wednesday, Dec. 18, according to Nikkei. 

Reuters also reported Hitachi has been reorganizing its business, selling non-core assets, while buying foreign businesses to help expand its digital businesses.

Toshiba followed a similar path in recent years, selling off its medical imaging division to Canon. All of the Japanese medical imaging companies have struggled to gain a larger portion of international market share outside of Japan. Consolidation of these companies in recent years has been seen as a way to increase market share and help build wider medical imaging portfolios. 

 

Related Content

Single-slice of the chest CT showing the abnormalities. Arrows indicate the location of the breast mass (red arrow), lymphadenopathy (blue arrow), and a lung nodule (yellow arrow). Arrows not present in experimental display. Image courtesy of Psychonomic Bulletin & Review

Single-slice of the chest CT showing the abnormalities. Arrows indicate the location of the breast mass (red arrow), lymphadenopathy (blue arrow), and a lung nodule (yellow arrow). Arrows not present in experimental display. Image courtesy of Psychonomic Bulletin & Review

Feature | Radiology Imaging | November 20, 2020
There’s a classic video demonstrating how our brains process information and allocate attention in which people bounc
1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well

1H-MR spectra of 3 consecutive patients with COVID-19. Upper row: Axial FLAIR images at the corona radiata level show representative MRS voxels (black squares) from sampled periventricular regions. Lower row: Corresponding spectrum (black) and LCModel fit (red) from each patient acquired at TE = 30 ms (upper row) and TE = 288 ms (lower row). A, A patient with COVID-19-associated multifocal necrotizing leukoencephalopathy shows diffuse patchy WM lesions with markedly increased Cho and decreased NAA, as well as elevated Lac. B, A patient with COVID-19 after recent PEA cardiac arrest with subtle FLAIR hyperintense white matter changes also shows elevated Cho/Cr and decreased NAA/Cr ratios. However, these derangements are less severe than in the patient in A. There is no clear elevation of Lac. C, A patient with COVID-19 without encephalopathy or recent severe hypoxia has normal Cho/Cr, with mildly decreased NAA/Cr and no lactate elevation. Cho, Choline; NAA, N-Acetyl-Aspartate; mI, Myo-Inositol; Lac, Lactate; Glx, Glutamate + Glutamine. Image courtesy of AJNR

News | Coronavirus (COVID-19) | November 19, 2020
November 19, 2020 — One of the first spectroscopic imaging-based studies of neurological injury in...
Videos | November 18, 2020
An example of a COVID-19 (SARS-CoV-2) pneumonia on chest computed tomography (CT) scan.
In partnership with Imaging Technology News, we collected feedback from more than 100 diagnostic imaging professionals including healthcare executives, radiology and IT leaders, radiologists, technologists, clinicians, and industry vendors regarding their perspective of the new virtual format, whether they’re attending, and if so what they’re hoping to get out of it. #RSNA20
Feature | Radiology Business | November 17, 2020 | By Laurie Lafleur
SyntheticMR, an innovative software solutions company for magnetic resonance imaging (MRI) announced today the company filed a 510(k) submission for its musculoskeletal solutions package, SyMRI MSK.
News | Magnetic Resonance Imaging (MRI) | November 17, 2020
November 17, 2020 — SyntheticMR, an innovative software solutions company for...
Acquisition expands Medtronic's artificial intelligence and data capabilities, becoming the first company to offer an integrated spine solution including AI-driven surgical planning, personalized spinal implants and robotic assisted surgery

Getty Images

News | Artificial Intelligence | November 16, 2020
November 16, 2020 — Medtronic announced that it has completed its friendly tender offer for France-based...
The term enterprise imaging (EI) entered our industry’s vernacular about a decade ago. It was introduced both as a concept and as an approach to managing patient images across the care continuum.

Getty Images

Feature | Enterprise Imaging | November 13, 2020 | By Jef Williams
The term enterprise imaging (EI) entered
Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.
Applying lessons learned during the pandemic for proactive assessment to support uptime and efficiency of imaging equipment
Feature | Coronavirus (COVID-19) | November 12, 2020 | By Martin Wimmer
As the COVID-19 pandemic spread around the world